Close Menu

At The New York Times Prescriptions blog, Duff Wilson says that outside business deals are keeping the pipelines of the major drug companies healthy, instead of internal research projects. According to a recent analysis from Fitch Ratings, the major drug makers are on pace to meet last year's level of 21 new drugs approved in the United States and Europe, but only thanks to acquisition and licensing deals.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.